The study includes three key outcomes : 1 ) clinical - the development of moderate to severe disease following an emergency department ( ED ) evaluation that employs a validated clinical score ( Modified Vesikari Scale ) ; 2 ) safety - side effect ; and 3 ) mechanism - fecal secretory immunoglobulin A levels .